Ochre Bio Ltd.
Industry
- Biotechnology
- Antisense, Oligonucleotides
- Drug Discovery Technologies
- Pharmaceuticals
Latest on Ochre Bio Ltd.
Fancy making a drug? You may want to create a diagnostic first. Ochre Bio Ltd. has taken a leaf out of the diagnostics industry’s book in its approach to developing RNA-based therapies to treat live
Rising Leaders Home Jack O’Meara is the CEO of Ochre Bio , a company working on a new technology platform for RNAi therapies, for chronic liver diseases He is also an executive that is not afraid to
Included for 2024 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, as well as individuals driving unique health initiatives worldwide. The 30 people below h
Nowadays, finding a drug target – which is a particular molecule specific to a disease which can be actioned upon – is harder than ever. In response, pharmaceutical companies both big and small are sp